Translational Health Science and Technology Institute

Last updated
Translational Health Science and Technology Institute
Established2009
Key peopleGagandeep Kang (Former-Executive Director)
Location
Faridabad, India

Translational Health Science and Technology Institute (THSTI) is a society registered under the Societies Registration Act XXI of 1860. It is also an autonomous institute of the Department of Biotechnology, Ministry of Science and Technology, Government of India. It was set up in 2009 at Gurgaon and is now located in NCR Biotech Science Cluster, Faridabad along with the Regional Center for Biotechnology, Advanced Technology Platforms Center, Small Animal Facility, and Bio-incubator. Envisioned by former secretary of DBT, M. K. Bhan, the centre was created to enable faster transition of lab research to market. Pramod Garg is the executive director of THSTI.

Contents

THSTI has six intramural centers namely Vaccine & Infectious Disease Research Centre (VIDRC), Pediatric Biology Centre (PBC), Centre for Bio-design & Diagnostics (CBD), Centre for Human Microbial Ecology (CHME), Policy Centre for Biomedical Research (PCBR), and Drug Discovery Research Centre (DDRC).

Vaccine & Infectious Disease Research Centre (VIDRC) is engaged in development of technologies pertaining to prophylaxis, treatment and diagnosis of infections caused by JEV, DENV, HIV, Rotavirus, Mycobaterium tuberculosis, HEV. In 2009, HIV Vaccine Translational Research (HVTR) laboratory was established in collaboration with International AIDS Vaccine Initiative, USA for developing efficient immunogens to be used in immunogenic composition against HIV. The laboratory works in collaboration with the US-based Scripps Research Institute, New York-based Weill Cornell Medical College, Amsterdam-based Academic Medical Center, and Johannesburg-based National Institute of Communicable Diseases. [1] In collaboration with Department of Biotechnology, Bharat Biotech International Limited, PATH and CHRD-SAS, VIDRC was also engaged in the phase III randomized, double-blind placebo controlled trial to evaluate the non-interference in the immune response of three doses of ORV 116E (Rotavac) to antigens contained in childhood vaccines and to assess the clinical lot consistency of three production lots. [2]

It also has one partnership center named Population Science Partnership Centre (PSPC) with the Centre for Health Research and Development, Society for Applied Studies (CHRD-SAS) and one extramural center named Clinical Development Services Agency (CDSA)to facilitate development of affordable healthcare products for public health diseases.

THSTI has more than 200 scientific publications in reputed scientific journals. It has also filed more than 30 patent applications in India and abroad.

Scientists at THSTI

Executive Director

Biotechnology Chair

Visiting Professor of Eminence

Related Research Articles

<span class="mw-page-title-main">Leiden University Medical Center</span> Hospital in ZA Leiden, Netherlands

Leiden University Medical Center or LUMC is the university hospital affiliated with Leiden University, of which it forms the medical faculty. It is located in Leiden, Netherlands. LUMC is a modern university medical center for research, education and patient care. Its research practice ranges from pure fundamental medical research to applied clinical research.

The National Institute of Allergy and Infectious Diseases is one of the 27 institutes and centers that make up the National Institutes of Health (NIH), an agency of the United States Department of Health and Human Services (HHS). NIAID's mission is to conduct basic and applied research to better understand, treat, and prevent infectious, immunologic, and allergic diseases.

The Kenya Medical Research Institute (KEMRI) is a state corporation established through the Science and Technology (Amendment) Act of 1979,, during the tenure of Nicholas Biwott as Minister of State, as the national body responsible for carrying out health research in Kenya.

<span class="mw-page-title-main">Walter Reed Army Institute of Research</span> Biomedical research facility administered by the U.S. Department of Defense

The Walter Reed Army Institute of Research (WRAIR) is the largest biomedical research facility administered by the U.S. Department of Defense (DoD). The institute is centered at the Forest Glen Annex, in the Forest Glen Park part of the unincorporated Silver Spring urban area in Maryland just north of Washington, DC, but it is a subordinate unit of the U.S. Army Medical Research and Development Command (USAMRDC), headquartered at nearby Fort Detrick, Maryland. At Forest Glen, the WRAIR has shared a laboratory and administrative facility — the Sen Daniel K. Inouye Building, also known as Building 503 — with the Naval Medical Research Center since 1999.

GeoVax is a clinical-stage biotechnology company which develops vaccines. GeoVax’s development platform uses Modified Vaccinia Ankara (MVA) vector technology, with improvements to antigen design and manufacturing capabilities. GeoVax uses recombinant DNA or recombinant viruses to produce virus-like particles (VLPs) in the person being vaccinated.

The Department of Biotechnology (DBT) is an Indian government department, under the Ministry of Science and Technology responsible for administrating development and commercialisation in the field of modern biology and biotechnology in India. It was set up in 1986.

<span class="mw-page-title-main">Centre for Neuroscience and Cell Biology</span>

The Centre for Neuroscience and Cell Biology (CNC) is a nonprofit research institute founded in 1990, aiming to foster research in biomedicine and biotechnology and multidisciplinary graduate teaching at the University of Coimbra. CNC was the first established “Laboratório Associado” in Portugal, and it has steadily increased the scope of scientific competences over the years, with a strong focus on the exploitation of the fundamental mechanisms of ageing and brain diseases.

<span class="mw-page-title-main">Intercell</span>

Intercell AG was a biotechnology company based in Vienna which focused on the development of modern prophylactic and therapeutic vaccines against infectious diseases. The company merged with Vivalis to form Valneva SE in 2012. Intercell was formed in 1998 as a spin-off of the Research Institute of Molecular Pathology (IMP) in Vienna. It employs 400 people in Austria, Scotland and the United States.

<span class="mw-page-title-main">Vaccine Research Center</span>

The Vaccine Research Center (VRC), is an intramural division of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), US Department of Health and Human Services (HHS). The mission of the VRC is to discover and develop both vaccines and antibody-based products that target infectious diseases.

The International Vaccine Institute (IVI) is an independent, nonprofit, international organization founded on the belief that the health of children in developing countries can be dramatically improved by the use of new and improved vaccines. Working in collaboration with the international scientific community, public health organizations, governments, and industry, IVI is involved in all areas of the vaccine spectrum – from new vaccine design in the laboratory to vaccine development and evaluation in the field to facilitating sustainable introduction of vaccines in countries where they are most needed.

Makerere University Walter Reed Project (MUWRP) was established in 2002 for the primary purpose of HIV vaccine development and building of vaccine testing capability in Uganda. It is one of the 5 international research sites established by the Department of Defense (DoD) United States HIV Research Program (MHRP), a program centered at the Walter Reed Army Institute of Research (WRAIR) in Silver Spring, Maryland. MUWRP's main facility is centrally located in Kampala, near the Makerere University College of Health Sciences where the MUWRP laboratory is located. The main facility includes the clinic, administrative, and data offices.

<span class="mw-page-title-main">Moderna</span> American biotechnology company

Virander Singh Chauhan is an Indian scientist and a Rhodes Scholar working in the fields of genetic engineering and biotechnology. He is known for his contributions to the development of a recombinant vaccine for malaria. and for synthetic structural peptides with biological functions. He was honored by the Government of India in 2012 with the fourth highest Indian civilian award of Padma Shri. He is the present Chancellor of the Gandhi Institute of Technology and Management.

Sanaria is a biotechnology company developing vaccines protective against malaria and other infectious diseases as well as related products for use in malaria research. Sanaria's vaccines are based on the use of the sporozoite (SPZ) stage of the malaria parasite, Plasmodium, as an immunogen, and as a platform technology for liver-vectored gene delivery. SPZ are normally introduced into humans by mosquito bite where they migrate to the liver and further develop to liver stages, and eventually back into the blood stream where the parasite infects red blood cells (RBC) and causes malaria. Plasmodium falciparum is the species responsible for more than 95% deaths caused by malaria. The WHO estimates there were 247 million clinical cases and 619,000 deaths in 2021 alone.

Gagandeep Kang FRS is an Indian microbiologist and virologist who is the Professor in the Department of Gastrointestinal Sciences at the Christian Medical College, Vellore, India and from August 2016 to July 2020 was executive director of the Translational Health Science and Technology Institute, Faridabad, an autonomous institute of the Department of Biotechnology, Ministry of Science and Technology, Government of India. Her major research focus is on viral infections in children, and the testing of rotaviral vaccines. She also works on other enteric infections and their consequences when children are infected in early life, sanitation and water safety. She was awarded the prestigious Infosys Prize in Life Sciences in 2016 for her contributions to understanding the natural history of rotavirus and other infectious diseases. In 2019, she became the first Indian woman to be elected as a Fellow of the Royal Society. She was on the Life Sciences jury for the Infosys Prize in 2020.

Sudhanshu Vrati is an Indian immunologist, microbiologist and the director of the Regional Centre for Biotechnology. Known for his studies in the fields of RNA virus replication and vaccine development, Vrati is an elected fellow of the National Academy of Sciences, India, Indian National Science Academy and the Indian Academy of Sciences. The Department of Biotechnology of the Government of India awarded him the National Bioscience Award for Career Development, one of the highest Indian science awards, for his contributions to biosciences in 2003.

Ramandeep Singh is an Indian molecular biologist, geneticist and a professor at the Translational Health Science and Technology Institute. Known for his studies on the pathogenesis of Mycobacterium tuberculosis, he is a former research fellow of the National Institutes of Health. The Department of Biotechnology of the Government of India awarded him the National Bioscience Award for Career Development, one of the highest Indian science awards, for his contributions to biosciences, in 2014.

<span class="mw-page-title-main">Hugh Auchincloss (immunologist)</span> American immunologist

Hugh Auchincloss, Jr., is an American immunologist and physician serving as the acting director of the National Institute of Allergy and Infectious Diseases since 2023. He previously served as the principal deputy director between 2006 and 2022. He was previously a transplant surgeon and professor of surgery at Harvard Medical School, and researched at Massachusetts General Hospital for 17 years.

<span class="mw-page-title-main">John R. Mascola</span> American Physician-Scientist

John R. Mascola is an American physician-scientist, immunologist and infectious disease specialist. He was the director of the Vaccine Research Center (VRC), part of the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH). He also served as a principal advisor to Anthony Fauci, director of NIAID, on vaccines and biomedical research affairs. Mascola is the current Chief Scientific Officer for ModeX Therapeutics.

BIOTECanada, or the Industrial Biotechnology Association of Canada, is a Canadian biotechnology industry association based in Ottawa, Ontario. It is an industry-funded membership organization composed of over 250 national and international pharmaceutical and gene therapy companies, medical device manufacturers, agricultural science businesses, law firms, academic institutions, research and development networks, advertising agencies, insurance companies and financial services firms.

References

  1. http://thsti.res.in/pdf/annualreport/AR_Eng15-16.pdf, Page 225
  2. http://thsti.res.in/pdf/annualreport/AR_Eng15-16.pdf, Page 172